Industry Growth Insights published a new data on “Meningococcal Vaccination Market”. The research report is titled “Meningococcal Vaccination Market research by Types (Polysaccharide, Conjugate, Combination), By Applications (Pneumonia, Meningitis, Bacteremia, Others), By Players/Companies GlaxoSmithKline, JN-International Medical, Novartis International, Sanofi, Pfizer, Baxter International, Biomed, Serum Institute of India”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Meningococcal Vaccination Market Research Report
By Type
Polysaccharide, Conjugate, Combination
By Application
Pneumonia, Meningitis, Bacteremia, Others
By Companies
GlaxoSmithKline, JN-International Medical, Novartis International, Sanofi, Pfizer, Baxter International, Biomed, Serum Institute of India
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
247
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Meningococcal Vaccination Market Report Segments:
The global Meningococcal Vaccination market is segmented on the basis of:
Types
Polysaccharide, Conjugate, Combination
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pneumonia, Meningitis, Bacteremia, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GlaxoSmithKline
- JN-International Medical
- Novartis International
- Sanofi
- Pfizer
- Baxter International
- Biomed
- Serum Institute of India
Highlights of The Meningococcal Vaccination Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Polysaccharide
- Conjugate
- Combination
- By Application:
- Pneumonia
- Meningitis
- Bacteremia
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Meningococcal Vaccination Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Meningococcal vaccination is a vaccine that helps protect people from meningitis, a serious bacterial infection of the brain and spinal cord. Meningococcal vaccines are available in two types: quadrivalent (four doses) and hexavalent (six doses). The quadrivalent vaccine protects against four different strains of meningococcus, while the hexavalent vaccine protects against six strains. Both vaccines are recommended for people aged 11 or older who do not have any other form of immunity protection against meningitis.
Some of the major companies in the meningococcal vaccination market are GlaxoSmithKline, JN-International Medical, Novartis International, Sanofi, Pfizer, Baxter International, Biomed, Serum Institute of India.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Meningococcal Vaccination Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Meningococcal Vaccination Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Meningococcal Vaccination Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Meningococcal Vaccination Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Meningococcal Vaccination Market Size & Forecast, 2018-2028
4.5.1 Meningococcal Vaccination Market Size and Y-o-Y Growth
4.5.2 Meningococcal Vaccination Market Absolute $ Opportunity
Chapter 5 Global Meningococcal Vaccination Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Meningococcal Vaccination Market Size Forecast by Type
5.2.1 Polysaccharide
5.2.2 Conjugate
5.2.3 Combination
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Meningococcal Vaccination Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Meningococcal Vaccination Market Size Forecast by Applications
6.2.1 Pneumonia
6.2.2 Meningitis
6.2.3 Bacteremia
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Meningococcal Vaccination Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Meningococcal Vaccination Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Meningococcal Vaccination Analysis and Forecast
9.1 Introduction
9.2 North America Meningococcal Vaccination Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Meningococcal Vaccination Market Size Forecast by Type
9.6.1 Polysaccharide
9.6.2 Conjugate
9.6.3 Combination
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Meningococcal Vaccination Market Size Forecast by Applications
9.10.1 Pneumonia
9.10.2 Meningitis
9.10.3 Bacteremia
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Meningococcal Vaccination Analysis and Forecast
10.1 Introduction
10.2 Europe Meningococcal Vaccination Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Meningococcal Vaccination Market Size Forecast by Type
10.6.1 Polysaccharide
10.6.2 Conjugate
10.6.3 Combination
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Meningococcal Vaccination Market Size Forecast by Applications
10.10.1 Pneumonia
10.10.2 Meningitis
10.10.3 Bacteremia
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Meningococcal Vaccination Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Meningococcal Vaccination Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Meningococcal Vaccination Market Size Forecast by Type
11.6.1 Polysaccharide
11.6.2 Conjugate
11.6.3 Combination
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Meningococcal Vaccination Market Size Forecast by Applications
11.10.1 Pneumonia
11.10.2 Meningitis
11.10.3 Bacteremia
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Meningococcal Vaccination Analysis and Forecast
12.1 Introduction
12.2 Latin America Meningococcal Vaccination Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Meningococcal Vaccination Market Size Forecast by Type
12.6.1 Polysaccharide
12.6.2 Conjugate
12.6.3 Combination
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Meningococcal Vaccination Market Size Forecast by Applications
12.10.1 Pneumonia
12.10.2 Meningitis
12.10.3 Bacteremia
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Meningococcal Vaccination Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Meningococcal Vaccination Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Meningococcal Vaccination Market Size Forecast by Type
13.6.1 Polysaccharide
13.6.2 Conjugate
13.6.3 Combination
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Meningococcal Vaccination Market Size Forecast by Applications
13.10.1 Pneumonia
13.10.2 Meningitis
13.10.3 Bacteremia
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Meningococcal Vaccination Market: Competitive Dashboard
14.2 Global Meningococcal Vaccination Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 GlaxoSmithKline
14.3.2 JN-International Medical
14.3.3 Novartis International
14.3.4 Sanofi
14.3.5 Pfizer
14.3.6 Baxter International
14.3.7 Biomed
14.3.8 Serum Institute of India
